Binding Affinity

Biomarker

Related News

Isomorphic Labs Unveils Proprietary AI Drug Discovery Model IsoDDE

Feb 28, 2026

Isomorphic Labs released a 27-page technical report on IsoDDE, its new AI drug-discovery engine that outperforms existing models in predicting drug-protein interactions and antibody structures, but the proprietary system offers limited technical details.

AI-Designed Drugs Achieve 90% Phase I Success Rate, Nearly Doubling Industry Average

Feb 26, 2026

Drug candidates designed via generative artificial intelligence are achieving a 90% success rate in Phase I safety trials in early 2026, nearly double the historical industry average of approximately 50%, while compressing development timelines from six years to under 18 months.